Taking pharmaceutical manufacturing beyond borders
Novagene Pharmaceuticals is building a strong foundation to serve pharmaceutical opportunities beyond the domestic market. With dedicated manufacturing blocks, controlled production environments, modern quality-control infrastructure and documented systems, Novagene is positioned to develop reliable manufacturing partnerships for international markets.
Our manufacturing platform is designed to support
- Consistent pharmaceutical manufacturing and supply
- Dedicated and segregated production environments
- Controlled manufacturing and documentation systems
- Advanced analytical and quality-control capabilities
- Product traceability and serialization
- Reliable production planning and supply continuity
- Regulatory-focused preparation for international opportunities
A 45,000 sq. ft. facility built for supply continuity
Novagene operates a 45,000 sq. ft. pharmaceutical manufacturing facility comprising three dedicated and segregated production blocks for Cephalosporins, Penicillins and Carbapenems.
The facility includes three dedicated QC departments, modern analytical equipment, dedicated raw-material and finished-goods areas, controlled HVAC systems, water-treatment infrastructure and documented manufacturing processes. Current production capacity averages approximately 3 million packs per month.
From Pakistan to international markets.
Novagene welcomes opportunities to work with international pharmaceutical companies, distributors and healthcare partners seeking dependable manufacturing capabilities from Pakistan.
Dependable manufacturing from Pakistan
Tell us which markets you serve and what you need to manufacture.